Modulating cGMP in Heart Failure

BMC Pharmacology
doi 10.1186/1471-2210-7-s1-s14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

cGMP Enhancing Strategies for Acute and Chronic Heart Failure

BMC Pharmacology
2005English

Changes in M6A RNA Methylation Contribute to Heart Failure Progression by Modulating Translation

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Effects of Thoracic Epidural Analgesia on Plasma cAMP and cGMP Levels in Patients With Heart Failure

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2013English

Is Enhancing cGMP-PKG Signalling a Promising Therapeutic Target for Heart Failure With Preserved Ejection Fraction?

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2016English

M-Atrial Natriuretic Peptide and Nitroglycerin in Experimental Acute Hypertensive Heart Failure: Differential Actions of Two cGMP Activating Therapeutics

BMC pharmacology & toxicology
MedicinePharmacology
2013English

Heart Failure

Endocrinology and Metabolism Clinics of North America
EndocrinologyMetabolismDiabetes
2018English

Pharmacogenomics in Heart Failure

Cardiology in Review
MedicineCardiovascular MedicineCardiology
2014English

Obscurin in Heart Failure

Biophysical Journal
Biophysics
2019English

Heart Failure

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy